Alleged violations of the Code during an event
If, as per your judgment, actions were taken during the conduct of a scientific event, with which the participation/sponsorship by a company that has signed the Code of Ethics of the Research-based Pharmaceutical Industry in Bulgaria raises doubts about a potential violation of the provisions of Article 10 of the Code, please report for them.
First National Medical Longevity Conference with international participation
Last update:
25/03/26
Organized by:
Bulgarian Longevity Association
Place:
Hilton Hotel Sofia
City:
Sofia
Start date:
06/11/26
End date:
08/11/26
App. Nr. of HCP:
200
Specialists:
Longevity medicine - endocrinologists, cardiologists, hepatologists, dermatologists, neurologists, psychiatrists, psychologists and other specialists
Website:
Any practice that might create confusion about the real scientific and educational purpose of scientific events sponsored by industry or to which industry sponsors HCPs should not be tolerated.
ARPharM Final Assessment:
08/10/26
Location and Venue
Hospitality Provided (Directly or Indirectly) to HCP
Син - Информация, която би позволила предварителна оценка, все още не е налична на уебсайта на събитието.
Other Activities
Information that would allow pre-assessment is not yet available on the event’s website. – The information available on the event’s website at the time of the pre- assessment doesn’t provide enough detail to allow a valuable pre- assessment.
Accompanying Persons
Информация, която би позволила предварителна оценка, все още не е налична на уебсайта на събитието.
Scientific Programme Schedule / Structure
Син - Налична е само предварителна програма; Пълната програма трябва да бъде налична най-късно 3 месеца преди събитието;
Legend
ARPharM’s pre-assessment process is ongoing.
Based on information provided through one of the ways described above (on the date indicated), arrangements would not raise concern with regard to provisions of the ARPharM Article 10 Code of Ethics provisions.
Based on information provided through one of the ways described above (on the date indicated), arrangements may raise concern with regard to provisions of the ARPharM Article 10 Code of Ethics provisions.
It is always recommended to check the rules prevailing under applicable national codes.
EXHIBITIONS: please read carefully the provisions of the ARPharM HCP Code and the additional guidance.